IL106878A0 - Diaryl piperazinoacetamide compounds - Google Patents
Diaryl piperazinoacetamide compoundsInfo
- Publication number
- IL106878A0 IL106878A0 IL106878A IL10687893A IL106878A0 IL 106878 A0 IL106878 A0 IL 106878A0 IL 106878 A IL106878 A IL 106878A IL 10687893 A IL10687893 A IL 10687893A IL 106878 A0 IL106878 A0 IL 106878A0
- Authority
- IL
- Israel
- Prior art keywords
- piperazinoacetamide
- diaryl
- compounds
- piperazinoacetamide compounds
- diaryl piperazinoacetamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92402435A EP0585500A1 (en) | 1992-09-04 | 1992-09-04 | Diaryl piperazineacetamides as antimuscarinic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL106878A0 true IL106878A0 (en) | 1993-12-28 |
Family
ID=8211704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL106878A IL106878A0 (en) | 1992-09-04 | 1993-09-02 | Diaryl piperazinoacetamide compounds |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP0585500A1 (fi) |
| JP (1) | JPH08501096A (fi) |
| AU (1) | AU668413B2 (fi) |
| CA (1) | CA2143744A1 (fi) |
| FI (1) | FI951009A0 (fi) |
| HU (1) | HUT71890A (fi) |
| IL (1) | IL106878A0 (fi) |
| MX (1) | MX9305248A (fi) |
| NZ (1) | NZ255176A (fi) |
| TW (1) | TW281674B (fi) |
| WO (1) | WO1994005648A1 (fi) |
| ZA (1) | ZA936362B (fi) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859295A (en) * | 1994-12-05 | 1999-01-12 | University Of Kentucky Research Foundation | Canavanine analogs and their use as chemotherapeutic agents |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| GB9513972D0 (en) * | 1995-07-08 | 1995-09-06 | Merck Sharp & Dohme | Pharmaceutical compositions |
| US6331553B1 (en) * | 1996-12-24 | 2001-12-18 | Chugai Seiyaku Kabushiki Kaisha | Aromatic amine derivatives having NOS inhibiting action |
| GB9709972D0 (en) * | 1997-05-19 | 1997-07-09 | Pfizer Ltd | Tetrazoles |
| CN1268938A (zh) * | 1997-07-24 | 2000-10-04 | 三菱东京制药株式会社 | 氨基环烷烃化合物 |
| BR9909555A (pt) * | 1998-04-08 | 2000-12-19 | Novartis Ag Novartis S A Novar | Herbicidas |
| US6511980B2 (en) | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| TW200301701A (en) | 2002-01-02 | 2003-07-16 | Ardent Pharmaceuticals Inc | Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| FR2840609A1 (fr) * | 2002-06-05 | 2003-12-12 | Lipha | Derives nitroso de la diphenylamine, compositions les contenant et leur utilisation en tant qu'antioxydants et donneurs spontanes d'oxyde nitrique |
| MXPA05003054A (es) * | 2002-09-20 | 2005-05-27 | Pfizer Prod Inc | Ligandos de amida y sulfonamida para el receptor de estrogenos. |
| US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| ES2644450T3 (es) | 2004-12-31 | 2017-11-29 | Dr. Reddy's Laboratories Ltd. | Nuevos derivados de bencilamina como inhibidores de CETP |
| TWI498115B (zh) | 2007-12-27 | 2015-09-01 | Daiichi Sankyo Co Ltd | 咪唑羰基化合物 |
| GB0815781D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| WO2011000945A2 (en) | 2009-07-03 | 2011-01-06 | Nensius Research A/S | Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| JP5964965B2 (ja) | 2011-08-18 | 2016-08-03 | ドクター レディズ ラボラトリーズ リミテッド | コレステリルエステル転送タンパク質（ｃｅｔｐ）インヒビターとしての置換複素環式アミン化合物 |
| MX352074B (es) | 2011-09-27 | 2017-11-08 | Dr Reddys Laboratories Ltd | Derivados de 5-bencilaminometil-6-aminopirazolo [3,4-b] piridina como inhibidores de proteina de transferencia de ester de colesterilo (cetp) utiles para el tratamiento de aterosclerosis. |
| BR112018071093A2 (pt) * | 2016-04-15 | 2019-01-29 | Epizyme Inc | composto de fórmula, composição farmacêutica, e método para prevenir ou tratar um distúrbio sanguíneo |
| AU2018254577B2 (en) | 2017-04-21 | 2024-06-13 | Epizyme, Inc. | Combination therapies with EHMT2 inhibitors |
| JPWO2022145408A1 (fi) * | 2020-12-28 | 2022-07-07 | ||
| CN117980302A (zh) * | 2021-08-10 | 2024-05-03 | 德克萨斯心脏研究所 | Lfa-1和vla-4的基于哌嗪的激动剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU209723B (en) * | 1990-10-31 | 1994-10-28 | Richter Gedeon Vegyeszet | Process for producing of piperazine derivatives |
| US5276155A (en) * | 1991-12-20 | 1994-01-04 | G. D. Searle & Co. | Process for the resolution of (±)-α-[2-[acetyl(1-methylethyl)amino]ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide |
| DE4314962A1 (de) * | 1993-05-06 | 1994-11-10 | Bayer Ag | Substituierte Piperazine |
-
1992
- 1992-09-04 EP EP92402435A patent/EP0585500A1/en not_active Withdrawn
-
1993
- 1993-07-29 JP JP6507184A patent/JPH08501096A/ja not_active Withdrawn
- 1993-07-29 AU AU47953/93A patent/AU668413B2/en not_active Ceased
- 1993-07-29 HU HU9500664A patent/HUT71890A/hu unknown
- 1993-07-29 CA CA002143744A patent/CA2143744A1/en not_active Abandoned
- 1993-07-29 WO PCT/US1993/007198 patent/WO1994005648A1/en not_active Application Discontinuation
- 1993-07-29 EP EP93918532A patent/EP0658157A1/en not_active Withdrawn
- 1993-07-29 NZ NZ255176A patent/NZ255176A/en unknown
- 1993-08-30 ZA ZA936362A patent/ZA936362B/xx unknown
- 1993-08-30 MX MX9305248A patent/MX9305248A/es unknown
- 1993-08-31 TW TW082107092A patent/TW281674B/zh active
- 1993-09-02 IL IL106878A patent/IL106878A0/xx unknown
-
1995
- 1995-03-03 FI FI951009A patent/FI951009A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2143744A1 (en) | 1994-03-17 |
| EP0585500A1 (en) | 1994-03-09 |
| HU9500664D0 (en) | 1995-04-28 |
| AU4795393A (en) | 1994-03-29 |
| NZ255176A (en) | 1996-02-27 |
| FI951009A (fi) | 1995-03-03 |
| EP0658157A1 (en) | 1995-06-21 |
| ZA936362B (en) | 1994-03-28 |
| TW281674B (fi) | 1996-07-21 |
| WO1994005648A1 (en) | 1994-03-17 |
| AU668413B2 (en) | 1996-05-02 |
| FI951009A0 (fi) | 1995-03-03 |
| JPH08501096A (ja) | 1996-02-06 |
| HUT71890A (en) | 1996-02-28 |
| MX9305248A (es) | 1995-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9501813D0 (en) | Anti-athero-sclerotic diaryl compounds | |
| AP9300508A0 (en) | Compounds | |
| GB9200245D0 (en) | Compounds | |
| GB9201755D0 (en) | Compounds | |
| GB9200210D0 (en) | Compounds | |
| ZA936362B (en) | Diaryl piperazinoacetamide compounds | |
| GB9201694D0 (en) | Compounds | |
| ZA937042B (en) | Diindolo compounds | |
| GB9201693D0 (en) | Compounds | |
| GB9200209D0 (en) | Compounds | |
| GB9200566D0 (en) | Compounds | |
| GB9201751D0 (en) | Compounds | |
| GB9202792D0 (en) | Compounds | |
| GB9201692D0 (en) | Compounds | |
| GB9226610D0 (en) | Compounds | |
| ZA944688B (en) | Diaryl compounds | |
| GB9201752D0 (en) | Compounds | |
| GB9203468D0 (en) | Compounds | |
| GB9203177D0 (en) | Compounds | |
| GB9201746D0 (en) | Compounds | |
| GB9203172D0 (en) | Compounds | |
| GB9201745D0 (en) | Compounds | |
| GB9201744D0 (en) | Compounds | |
| GB9201748D0 (en) | Compounds | |
| GB9209408D0 (en) | Compounds |